Management
Stephen M. Simes (President and Chief Executive Officer)
Stephen M. Simes has served as our Vice Chairman, President and a director of our company since January 1998 and Chief Executive Officer since March 1998.
From October 1994 to January 1997, Mr. Simes was President, Chief Executive Officer and a Director of Unimed Pharmaceuticals, Inc., a company with a product focus on infectious diseases, AIDS, endocrinology and oncology. From 1989 to 1993, Mr. Simes was Chairman, President and Chief Executive Officer of Gynex Pharmaceuticals, Inc., a company which concentrated on the AIDS, endocrinology, urology and growth disorders markets. In 1993, Gynex was acquired by Bio-Technology General Corp., and from 1993 to 1994, Mr. Simes served as Senior Vice President and Director of Bio-Technology General Corp. Mr. Simes' career in the pharmaceutical industry started in 1974 with G.D. Searle & Co.
Phillip B. Donenberg, CPA (Chief Financial Officer, Treasurer and Secretary)
Phillip B. Donenberg, CPA has served as our Chief Financial Officer, Treasurer and Secretary since July 1998.
Before joining our company, Mr. Donenberg was Controller of Unimed Pharmaceuticals, Inc. from January 1995 to July 1998. From 1993 to 1994, Mr. Donenberg was Controller of Molecular Geriatrics Corporation, a biotechnology corporation. Prior to Molecular Geriatrics Corporation, Mr. Donenberg held similar positions with other pharmaceutical companies, including Gynex Pharmaceuticals, Inc. and Xtramedics, Inc.
Joy A. Thomas (Vice President of Corporate Development)
Joy A. Thomas has served as our Vice President of Corporate Development since August, 2007.
Before joining our company, Ms. Thomas was with Baxter Healthcare Corporation for 13 years where she was most recently Senior Director, Global Strategy & Business Development. Throughout her tenure at Baxter, Ms. Thomas held various finance, marketing and business development positions of increasing responsibility. Ms. Thomas holds a Bachelor of Science degree in Finance and Russian from the University of Illinois, and a Master of Business Administration in International Business and Finance from the University of Chicago.
Bill Milling (Controller and Senior Director of Operations)
Bill Milling, CPA, has served as our Controller and Senior Director of Operations since October, 2004.
Before joining our company, Mr. Milling was the Controller of Dor BioPharma from March 2002 to September 2004. From 1994 to 2002, Mr. Milling was with CCH, Inc. where he held various financial and systems positions of increasing responsibility. Mr. Milling holds a Bachelor of Science degree in Accountancy from Eastern Illinois University.
Michael C. Snabes (Vice President of Clinical Development)
Michael C. Snabes M.D., Ph.D. has served as our Vice President of Clinical Development since April, 2008. Dr. Snabes has served as a medical consultant to BioSante on clinical and regulatory matters since November, 2005. Dr. Snabes is a board certified reproductive endocrinologist, as well as holding a Ph.D. in physiology and reproductive endocrinology.
Before joining our company, Dr. Snabes was an Associate Professor in the Section of Reproductive Endocrinology and Infertility in the Department of Obstetrics and Gynecology at The University of Chicago Pritzker School of Medicine. From 2003 to 2004, Dr. Snabes served as Medical Advisor in Clinical Research and Development in Inflammation, Arthritis, and Pain at Pfizer, Inc. and from 1999-2003 in the same position at Pharmacia, Inc. where he worked on the successful development of the COX-2 inhibitors, Celebrex and Bextra. From 1997 to 1999, Dr. Snabes served as Associate Director in Clinical Research in Women's Health at Searle/Monsanto. Dr. Snabes is an elected Fellow of the American College of Obstetrics and Gynecology, the American College of Surgeons and the American College of Endocrinology. Dr. Snabes is the author of more than 135 publications and abstracts.
